Ferrer Internacional S.A.

Tweet this page
<
2015
2016
2017
2018
2019
>
No longer registered as of 19 Dec 2020 - Registration as it was on 18 Dec 2019
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

37,500€

Financial year: Jan 2018 - Dec 2018

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    Ferrer Internacional S.A.   (Ferrer)

    EU Transparency Register

    775072817180-24 First registered on 29 Apr 2015

    Goals / Remit

    Ferrer contributes to people’s health and quality of life through the pharmaceutical, health, fine chemicals and food sectors. Our mission is to advance the wellbeing of society. We discover, research and develop medicines, diagnostics, vaccines, fine chemicals, food and feed.
    Ferrer has diversification across the whole healthcare spectrum. Prescription drugs, hospital equipment, molecular diagnostics, vaccines, over-the-counter remedies, dermocosmetics, nutritional supplements: we offer a wide range of products meeting the highest scientific standards.
    Ferrer also boasts a solid industrial structure. Our certified manufacturing centres produce chemicals and finished pharmaceuticals to the most rigorous standards.
    Ferrer: Making People Better

    Main EU files targeted

    Health Systems Performance Assessment
    Health Technology Assessment
    Pharmaceuticals in the environment
    Clinical Trials Regulation
    Data Protection Regulation
    Medical Devices Regulation
    Access to innovation
    Industrial Policy
    EU Trade Policy

    Address

    Head Office
    Avenida Diagonal, 549
    Barcelona 08029
    SPAIN
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 19 Apr 2024

    Name Start date End Date
    Mr Alfredo Gracia Canales 08 Mar 2019 07 Mar 2020
    Mr Alfredo Gracia Canales 22 Mar 2018 08 Mar 2019
    Mr Alfredo Gracia Canales 05 Apr 2017 22 Mar 2018
    Mr Alfredo Gracia Canales 21 Apr 2016 05 Apr 2017

    Complementary Information

    1 única persona ocupa aproximadamente menos de un 25% de su tiempo total en las actividades antes señaladas

    Person in charge of EU relations

    Mr Alfredo Gracia (Corporate Director, Patient Advocacy & Public Affairs)

    Person with legal responsibility

    Mr Mario Rovirosa Escosura (CEO)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    FARMAINDUSTRIA
    FENIN
    ANDI
    ANEFP

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2018 - Dec 2018

    Lobbying costs for closed financial year

    37,500€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 29 Nov 2017 Location Brussels
      Subject Treatment of cardiovascular diseases
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 15 Jul 2015 Location Brussels
      Subject Prevention of secondary cardiovascular incidents
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
Download this datacard